A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

NCT02740985 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies
Non-Small Cell Lung Cancer (NSCLC)
Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)
Colorectal Carcinoma (CRC)

Interventions

DRUG: AZD4635
DRUG: Durvalumab
DRUG: Abiraterone Acetate
DRUG: Enzalutamide
DRUG: Oleclumab
DRUG: Docetaxel

Sponsor

AstraZeneca